Literature DB >> 18765186

Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008.

David O Taylor1, Leah B Edwards, Paul Aurora, Jason D Christie, Fabienne Dobbels, Richard Kirk, Axel O Rahmel, Anna Y Kucheryavaya, Marshall I Hertz.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18765186     DOI: 10.1016/j.healun.2008.06.017

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  37 in total

1.  Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.

Authors:  Michele Pighi; Fabrizio Tomai; Alessandro Petrolini; Leonardo de Luca; Giuseppe Tarantini; Alberto Barioli; Paola Colombo; Silvio Klugmann; Marco Ferlini; Maurizio Ferrario Ormezzano; Bruno Loi; Paolo Calabrò; Renato Maria Bianchi; Giuseppe Faggian; Alberto Forni; Corrado Vassanelli; Marco Valgimigli; Flavio Ribichini
Journal:  J Cardiovasc Transl Res       Date:  2015-12-18       Impact factor: 4.132

2.  Incidence and outcome of abdominal surgical interventions following lung transplantation--a single center experience.

Authors:  Kai Timrott; Florian W R Vondran; Mark D Jaeger; Jens Gottlieb; Juergen Klempnauer; Thomas Becker
Journal:  Langenbecks Arch Surg       Date:  2011-03-12       Impact factor: 3.445

3.  Cardiac cell therapy: the next (re)generation.

Authors:  Elvira Forte; Isotta Chimenti; Lucio Barile; Roberto Gaetani; Francesco Angelini; Vittoria Ionta; Elisa Messina; Alessandro Giacomello
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

4.  Commentaries on Viewpoint: V̇o2peak is an acceptable estimate of cardiorespiratory fitness but not V̇o2max.

Authors:  Paulo Azevedo; Dharini M. Bhammar; Tony G. Babb; T. Scott Bowen; Klaus K. Witte; Harry B. Rossiter; Julien V. Brugniaux; Ben D. Perry; Ricardo Dantas de Lucas; Tiago Turnes; Jeann L. Sabino-Carvalho; Thiago Ribeiro Lopes; Rodrigo Zacca; Ricardo J. Fernandes; Greg L. McKie; Tom J. Hazell; Lucas Helal; Anderson Donelli da Silveira; Craig Ryan McNulty; Robert Andrew Roberg; Tom E. Nightingale; Abdullah A. Alrashidi; Evgeny Mashkovskiy; Andrei Krassioukov; Pierre Clos; Davy Laroche; Benjamin Pageaux; David C. Poole; Andrew M. Jones; Gustavo Z. Schaun; Diego Santos de Souza; Tatiane de Oliveira Barreto Lopes; Mary Vagula; Li Zuo; Tingyang Zhao
Journal:  J Appl Physiol (1985)       Date:  2018-07-01

5.  Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.

Authors:  George J Arnaoutakis; Timothy J George; Arman Kilic; Claude A Beaty; Eric S Weiss; John V Conte; Ashish S Shah
Journal:  Ann Thorac Surg       Date:  2012-03-17       Impact factor: 4.330

6.  Wideband arrhythmia-Insensitive-rapid (AIR) pulse sequence for cardiac T1 mapping without image artifacts induced by an implantable-cardioverter-defibrillator.

Authors:  KyungPyo Hong; Eun-Kee Jeong; T Scott Wall; Stavros G Drakos; Daniel Kim
Journal:  Magn Reson Med       Date:  2015-05-14       Impact factor: 4.668

Review 7.  A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure.

Authors:  Siyamek Neragi-Miandoab
Journal:  Surg Today       Date:  2012-07-20       Impact factor: 2.549

8.  Control the platelets, control the disease: A novel cystic fibrosis hypothesis.

Authors:  Siobhan Branfield; A Valance Washington
Journal:  J Thromb Haemost       Date:  2020-05-28       Impact factor: 5.824

Review 9.  Nucleic acid drugs for prevention of cardiac rejection.

Authors:  Jun-ichi Suzuki; Mitsuaki Isobe; Ryuichi Morishita; Ryozo Nagai
Journal:  J Biomed Biotechnol       Date:  2009-12-31

Review 10.  Management of end-stage heart failure: a perspective on the Arab Gulf states.

Authors:  Waleed Al Habeeb; Garrick C Stewart; Gilbert H Mudge
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.